ImmunogenX

ImmunogenX, Inc. is a clinical-stage company focused on research in therapeutics, disease management, and food safety. For individuals with celiac disease, the only current option is to adhere to a lifelong gluten-free diet (GFD). Additionally, a minimally invasive diagnostic tool (CypCel)™ has been developed for celiac disease management, based on a clinically relevant metabolic marker compound that evaluates the recovery status of celiac patients adhering to a gluten-free diet or other treatments.